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Identity 
Other names: LRP16 
HGNC (Hugo): MACROD1 
Location: 11q13.1 
Local order: Next to OTUB1 and FLRT1. 
Note 
MACROD1/LRP16 is a member of macro domain 
protein family, which contains only a stand-alone 
macro domain functional module at its C-terminus. 
Through its macro domain module LRP16 binds poly 
(A), mono (ADP-ribose) or poly (ADP-ribose). LRP16 
is an estrogen and androgen-responsive gene. Both 
estrogen receptor alpha (ERalpha) and androgen 
receptor (AR) can bind to LRP16 promoter to enhance 
its transcription. LRP16 also acts as a co-activator of 
ERalpha, AR, and possible other nuclear receptors, and 
nuclear factor-kappaB (NF-kappaB) to activate their 
transcriptional activities. Keratin 18 can associate with 
LRP16, by which LRP16 was sequestrated in the 
cytoplasm. In addition, LRP16 can recruit to chromatin 
when cells were exposed to ironing radiation (IR) by 
sensing poly (ADP-ribose) synthesized by PARP1, 
indicating that LRP16 is involved in IR-induced DNA-
damage response. 
DNA/RNA 
Note 
MACROD1/LRP16, encoding a 35 kD protein, was 
originally isolated from human lymphocytes. The 
proximal region (nt-676 to -24) of the human LRP16 
promoter contains a 1/2 estrogen response element 
(ERE)/Sp1 site and multiple GC-rich elements that 
confer estrogenic responsiveness and are sufficient for 
estrogenic action. In the presence of estrogen, ERalpha 
and Sp1 complex recruits to the LRP16 gene promoter 
to enhance LRP16 transcription. 
Description 
Genomic structure of LRP16: spans 167 kb; 11 exons; 
ORF: 975 bp. 
Transcription 
LRP16 mRNA (NM_014067.3) has a size of 1256 bp. 
Exons: 11; transcript length: 1256 bp; translation 
length: 325 residues. 
Pseudogene 
No pseudogenes reported. 
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Protein 
Note 
MACROD1/LRP16 contains a single macro domain 
(Appr-1"-pase_ like). It contains an ADP-ribose-
binding pocket through which it can bind mono (ADP-
ribose). Moreover, LRP16 also can bind poly (ADP-
ribose) and hydrolyze ADP-ribose-1" phosphate to 
yield ADP-ribose. Therefore, it is reasonable to 
propose that LRP16 may play an important role in the 
ADP-ribosylation of proteins, an important post-
translational modification which occurs in DNA repair, 
transcription, chromatin biology, and long-term 
memory formation. 
Description 
325 amino acids; 35.505 kDa; containing a single 
macro domain (from amino acid 141 to 322). 
Expression 
LRP16 is expressed ubiquitously in nearly all types of 
tissues and is up-regulated in hormone-dependent 
cancer cells such as MCF-7 breast cancer cells, 
Ishikawa endometrial cancer cells, and BG-1 ovarian 
cancer cells upon estrogenic stimulation. Conversely, 
estrogen reduces LRP16 expression in estrogen-
resistant SKOV-3 ovarian cancer cells. Androgen also 
up-regulates LRP16 expression in androgen-sensitive 
prostate cancer cells. In addition, LRP16 is frequently 
over-expressed in several tumor tissues by comparison 
with their corresponding normal tissues. 
Localisation 
Nuclear, cytoplasm and mitochondrion. 
Function 
1. LRP16 can recruit to DNA-damaged sites through 
sensing radiation-induced activation of poly-ADP-
ribose polymerase-1 (PARP1). 
2. LRP16 can interact with both ERalpha and AR to 
enhance their transcriptional activities. 
3. Cytokeratin 18 (K18) can interact with LRP16 
through its C-terminal region and sequester LRP16 in 
the cytoplasm, by which the LRP16 co-activation of 
ERalpha is inactivated. 
4. LRP16 can bind to p65, a component of NF-kappaB, 
and participates into the NF-kappaB enhanceosome to 
enhance TNFalpha-induced NF-kappaB activity (our 
unpublished data). 
Homology 
- Bos taurus: MACROD1; 
- Pan troglodytes: MACROD1; 
- Canis lupus familiaris: MACROD1; 
- Rattus norvegicus: Macrod1; 
- Mus musculus: Macrod1; 
- Danio rerio: zgc: 92353; 
- Magnaporthe grisea: MGG_09394; 
- Neurospora crassa: NCU07925.1. 
Implicated in 
Prostate cancer 
Note 
Androgen up-regulates LRP16 expression in both 
mRNA and protein levels in androgen-sensitive 
prostate cancer cells such as LNCaP cells, but not in 
prostate cancer cells without overexpression of LRP16, 
which significantly stimulates cell growth in the 
presence of androgen. Reversely, inhibition of the 
endogenous LRP16 in androgen-sensitive prostate 
cancer cells markedly diminishes androgen-stimulated 
cell growth. LRP16 is not only a target of AR in 
androgen-sensitive prostate cancer cells, but also a 
coactivator of AR. By the AR-LRP16 feedback 
pathway, LRP16 may play an important role in the 
progression of androgen-sensitive prostate cancers. 
Estrogen-dependent breast cancer and 
endometrial cancer 
Note 
LRP16 is not only a target gene of ERalpha, but also an 
ERalpha coactivator. LRP16 overexpression 
significantly promotes MCF-7 cell proliferation. 
Reversely, knockdown of LRP16 in MCF-7 cells 
markedly impaired estrogen-stimulated ERalpha 
activity and cell growth. LRP16 overexpression was 
observed in more than 30% primary breast cancers. 
LRP16 represses E-cadherin (a molecule associated  
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with cell adhesion and tumor metastasis) expression 
through antagonizing the binding of ERalpha to the E-
cadherin promoter. Inhibition of LRP16 expression in 
both estrogen-responsive MCF-7 breast cancer and 
Ishikawa endometrial cancer cells significantly 
attenuates their invasive capacity. 
Collectively, LRP16 may be involved in the 
progression of estrogen-dependent cancers. 
Gastric carcinoma 
Note 
The expression level of LRP16 in primary gastric 
carcinoma tissues was significantly higher than that in 
normal mucosa tissues. In addition, overexpression of 
LRP16 was positively linked with tumor size, depth of 
invasion, lymph node metastasis, distant metastasis and 
TNM stage. Higher expression of LRP16 predicts a 
poor prognosis of gastric carcinoma patients. 
Colorectal carcinoma 
Note 
The higher expression level of LRP16 was found to be 
positively associated with the poor differentiation of 
primary human colorectal carcinomas. In addition, 
higher expression of LRP16 in primary human 
colorectal carcinomas was also linked to poor 
prognosis of patients. 
Prognosis 
LRP16 overexpression predicts a poor prognosis in 
several tumors. 
t(11;21)(q13;q22) in myelodysplastic 
syndrome 
Hybrid/Mutated gene 
A kind of chromosome rearrangement 
t(11;21)(q13;q22), involved in RUNX1 (also known as 
AML1) and LRP16, was found in a patient with 
monocytic leukemia evolving from myelodysplastic 
syndrome (MDS). The fusion junction of hybrid gene 
RUNX1-LRP16 has two types, involving either exon 5 
or exon 6 of RUNX1 and exon 2 of LRP16. The 
reciprocal LRP16-RUNX1 chimera is a fusion between 
exon 1 of LRP16 and exon 7 of RUNX1. 
Abnormal protein 
Both RUNX1 (exon 5)-LRP16 and RUNX1 (exon 6)-
LRP16 retain the RUNT domain (RD) of RUNX1 and 
the macro domain of LRP16, whereas reciprocal 
LRP16-RUNX1 retains the transactivation domain 
(TA) of RUNX1. The formation of fusion protein 
RUNX1-LRP16 may lead to the inhibition of myeloid 
differentiation and contributes to leukemia genesis. 
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